Information:
Fel:
ID
22962
Beskrivning
Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation; ODM derived from: https://clinicaltrials.gov/show/NCT00974272
Länk
https://clinicaltrials.gov/show/NCT00974272
Nyckelord
Versioner (1)
- 2017-06-18 2017-06-18 -
Uppladdad den
18 juni 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Type 2 Diabetes Mellitus NCT00974272
Eligibility Type 2 Diabetes Mellitus NCT00974272
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT00974272
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Diabetes Mellitus Type 2
Item
recently diagnosed type 2 diabetes (within 3 years) on diet or igt
boolean
C0011860 (UMLS CUI [1])
Fasting triglyceride levels
Item
fasting triglyceride levels >140 and < 400 mg/dl and values varying less than 35% between two screening measurements
boolean
C0582824 (UMLS CUI [1])
Liver function, White Blood Cell Count
Item
normal liver function tests and white blood cell count
boolean
C0232741 (UMLS CUI [1])
C0023508 (UMLS CUI [2])
C0023508 (UMLS CUI [2])
HbA1c
Item
type 2 diabetes for > 3 years or hba1c ≥ 7.5
boolean
C0019018 (UMLS CUI [1])
Diabetes Mellitus Type 1
Item
known or suspected type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Diabetes medications, Insulin treatment
Item
any diabetes medications in the past 3 weeks, tzd in the prior 3 months or prior regular use of insulin
boolean
C3842789 (UMLS CUI [1])
C0745343 (UMLS CUI [2])
C0745343 (UMLS CUI [2])
Creatinine
Item
creatinine > 2.0 mg/dl or other evidence of active kidney disease
boolean
C0201976 (UMLS CUI [1])
Measurement of liver enzyme
Item
hepatic enzyme elevation > 2x normal
boolean
C0428321 (UMLS CUI [1])
Nonalcoholic fatty liver disease
Item
known nonalcoholic fatty liver disease
boolean
C0400966 (UMLS CUI [1])
Gastrointestinal or pancreatic problems
Item
malabsorption of fat or other nutrients, severe lactose intolerance or other significant gastrointestinal or pancreatic problems
boolean
C0017178 (UMLS CUI [1])
C0030286 (UMLS CUI [2])
C0030286 (UMLS CUI [2])
Nausea or vomiting
Item
recent history of nausea or vomiting
boolean
C0027497 (UMLS CUI [1])
C0042963 (UMLS CUI [2])
C0042963 (UMLS CUI [2])
Active Infection
Item
acute bacterial or viral illness or evidence of other active infection in the past 4 weeks
boolean
C0009450 (UMLS CUI [1])
Cardiovascular event, Angina, Major illness
Item
a prior cardiovascular event, stable or unstable angina or other major illness in the past 6 months
boolean
C1320716 (UMLS CUI [1])
C0002962 (UMLS CUI [2])
C0009488 (UMLS CUI [3])
C0002962 (UMLS CUI [2])
C0009488 (UMLS CUI [3])
Pharmacotherapy
Item
current regular use of anti-inflammatory medications or antioxidants, including over the counter medications and high dose salicylates (>1 g/day)
boolean
C0013216 (UMLS CUI [1])
Lipid-lowering therapy
Item
any lipid lowering therapy in the prior 3 weeks other than a statin medication. subjects receiving a statin medication must be on a stable dose for at least 2 months prior to participation.
boolean
C0585943 (UMLS CUI [1])